R.s 2019 study, Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment, opioid withdrawal symptoms, driven by noradrenergic hyperactivity, create a severe barrier to recovery
In the last decade, studies on the condition of BBB in neurodegenerative diseases, including ALS, have demonstrated the presence of vascular disruption, a condition that could theoretically favour the entry of drugs into brain regions affected by neurodegeneration
The short cut utilizes BHMT, while the long route is via MTR/MTRR and Vitamin B12 (Yasko, 2013)
Hope you could understand
it is not standard practice in UK clinical settings, where single-use Water for Injections BP is the norm